Trial Profile
Pharmacokinetics and efficacy of Ustekinumab in Crohn's disease
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 30 Jan 2020
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 06 Mar 2019 Planned number of patients changed from 40 to 120.
- 31 Jul 2018 New trial record